• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国医疗保险人群中 1996-2008 年皮肤癌治疗与费用分析。

Analysis of skin cancer treatment and costs in the United States Medicare population, 1996-2008.

机构信息

Advanced Dermatology, Norwich, Connecticut, USA.

出版信息

Dermatol Surg. 2013 Jan;39(1 Pt 1):35-42. doi: 10.1111/dsu.12024. Epub 2012 Nov 30.

DOI:10.1111/dsu.12024
PMID:23199014
Abstract

BACKGROUND

There is a skin cancer epidemic in the United States.

OBJECTIVE

To examine skin cancer treatment modality, location, and cost and physician specialty in the Medicare population from 1996 to 2008.

METHODS

Centers for Medicare and Medicaid Services databases were used to examine skin cancer treatment procedures performed for Medicare beneficiaries.

RESULTS

From 1996 to 2008, the total number of skin cancer treatment procedures [malignant excision, destruction, and Mohs micrographic surgery (MMS)] increased from 1,480,645 to 2,152,615 (53% increase). The numbers of skin cancers treated by excision and destruction increased modestly (20% and 39%, respectively), but the number of MMS procedures increased more rapidly (248% increase). Dermatologists treated an increasing percentage (75-82%) of skin cancers during these years, followed by plastic and general surgery. In 2008, more than 90% of all skin cancers were treated in the office, with the remainder being treated in facility-based settings. Allowable charges paid to physicians by Medicare Part B for skin cancer treatments increased 137% from 1996 to 2008, from $266,960,673 to $633,448,103.

CONCLUSIONS

The number of skin cancer treatment procedures increased substantially from 1996 to 2008, as did overall costs to Medicare. Dermatologists treated the vast majority of skin cancers in the Medicare population, using a mix of treatment modalities, almost exclusively in the office setting.

摘要

背景

美国正面临着皮肤癌高发的严峻形势。

目的

从 1996 年至 2008 年,对 Medicare 人群中的皮肤癌治疗方式、部位、费用和医生专业进行研究。

方法

使用医疗保险和医疗补助服务中心数据库,对 Medicare 受益人的皮肤癌治疗程序进行了检查。

结果

从 1996 年至 2008 年,皮肤癌治疗程序(恶性切除、破坏和 Mohs 显微外科手术(MMS))的总数从 1,480,645 例增加到 2,152,615 例(增加了 53%)。切除和破坏治疗的皮肤癌数量略有增加(分别增加了 20%和 39%),但 MMS 程序的数量增加更快(增加了 248%)。这些年来,皮肤科医生治疗的皮肤癌比例不断增加(75-82%),其次是整形外科和普通外科。2008 年,超过 90%的皮肤癌在办公室治疗,其余在医疗机构治疗。从 1996 年到 2008 年,医疗保险 B 部分向皮肤科医生支付的皮肤癌治疗费用增加了 137%,从 266,960,673 美元增加到 633,448,103 美元。

结论

从 1996 年至 2008 年,皮肤癌治疗程序的数量大幅增加,医疗保险的总费用也随之增加。皮肤科医生在 Medicare 人群中治疗了绝大多数皮肤癌,使用了多种治疗方式,几乎全部在办公室环境中进行。

相似文献

1
Analysis of skin cancer treatment and costs in the United States Medicare population, 1996-2008.美国医疗保险人群中 1996-2008 年皮肤癌治疗与费用分析。
Dermatol Surg. 2013 Jan;39(1 Pt 1):35-42. doi: 10.1111/dsu.12024. Epub 2012 Nov 30.
2
Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.医疗保险人群中莫氏显微外科手术和手术切除治疗非黑色素瘤皮肤癌的情况
Arch Dermatol. 2012 Apr;148(4):473-7. doi: 10.1001/archdermatol.2011.2456.
3
Cost effectiveness of Mohs micrographic surgery: review of the literature.莫氏显微外科手术的成本效益:文献综述
J Drugs Dermatol. 2009 Oct;8(10):914-22.
4
Mohs micrographic surgery utilization in the Medicare population, 2009.2009 年 Medicare 人群中 Mohs 显微外科手术的应用情况。
Dermatol Surg. 2012 Sep;38(9):1427-34. doi: 10.1111/j.1524-4725.2012.02464.x. Epub 2012 Jun 8.
5
Incidence estimate of nonmelanoma skin cancer in the United States, 2006.2006年美国非黑色素瘤皮肤癌的发病率估计
Arch Dermatol. 2010 Mar;146(3):283-7. doi: 10.1001/archdermatol.2010.19.
6
Cost analysis: Mohs micrographic surgery.成本分析:Mohs 显微外科手术。
Dermatol Surg. 2012 Apr;38(4):585-94. doi: 10.1111/j.1524-4725.2012.02341.x. Epub 2012 Mar 22.
7
Skin biopsy and skin cancer treatment use in the Medicare population, 1993 to 2016.1993 年至 2016 年医疗保险人群的皮肤活检和皮肤癌治疗应用。
J Am Acad Dermatol. 2021 Jan;84(1):53-59. doi: 10.1016/j.jaad.2020.06.030. Epub 2020 Jun 15.
8
Ambulatory surgery centers and interventional techniques: a look at long-term survival.门诊手术中心和介入技术:长期生存情况观察。
Pain Physician. 2011 Mar-Apr;14(2):E177-215.
9
Mohs Micrographic Surgery Volume and Payment Patterns Among Dermatologists in the Medicare Population, 2013.2013年医疗保险人群中皮肤科医生的莫氏显微外科手术量及支付模式
Am J Clin Oncol. 2018 Dec;41(12):1199-1203. doi: 10.1097/COC.0000000000000448.
10
Saga of payment systems of ambulatory surgery centers for interventional techniques: an update.门诊手术中心介入技术支付系统的传奇:最新进展。
Pain Physician. 2012 Mar-Apr;15(2):109-30.

引用本文的文献

1
Patient Preferences and Cosmetic Outcomes Following Destructive Treatments for Non-facial Basal Cell Carcinoma: A Mixed Methods Study.非面部基底细胞癌破坏性治疗后的患者偏好与美容效果:一项混合方法研究
Acta Derm Venereol. 2025 Feb 12;105:adv41325. doi: 10.2340/actadv.v105.41325.
2
Melanoma-related costs by disease stage and phase of management in Ireland.爱尔兰不同疾病阶段和管理阶段的黑色素瘤相关成本。
J Public Health (Oxf). 2023 Aug 28;45(3):714-722. doi: 10.1093/pubmed/fdac154.
3
Use of the O-Z flap as an alternative to free tissue transfer for reconstruction of large scalp defects.
使用O-Z皮瓣替代游离组织移植来重建大面积头皮缺损。
World J Otorhinolaryngol Head Neck Surg. 2022 Apr 30;8(4):355-360. doi: 10.1016/j.wjorl.2021.04.006. eCollection 2022 Dec.
4
Declining commercial market share in facial reconstructive surgery: Implications for academic plastic surgery and training future generations.面部重建手术商业市场份额的下降:对整形外科学术和培训下一代的影响。
J Plast Reconstr Aesthet Surg. 2022 Dec;75(12):4484-4493. doi: 10.1016/j.bjps.2022.08.071. Epub 2022 Aug 27.
5
Curettage vs. cryosurgery for superficial basal cell carcinoma: a prospective, randomised and controlled trial.刮除术与冷冻疗法治疗表浅性基底细胞癌:一项前瞻性、随机对照临床试验。
J Eur Acad Dermatol Venereol. 2022 Oct;36(10):1758-1765. doi: 10.1111/jdv.18209. Epub 2022 May 21.
6
Toll-Like Receptor-4 Antagonist Enhances the Repair of Ultraviolet Radiation-Induced DNA Damage and Augments Anti-Tumor Immune Responses in Mice.Toll样受体4拮抗剂增强紫外线诱导的DNA损伤修复并增强小鼠的抗肿瘤免疫反应。
Cancers (Basel). 2021 Oct 28;13(21):5406. doi: 10.3390/cancers13215406.
7
Extended Scalp Flaps for Extensive Soft Tissue Scalp Defects as a Day Surgery Procedure Under Local Anesthetic: A Single Centre Experience.局部麻醉下作为日间手术的扩展头皮皮瓣修复广泛头皮软组织缺损:单中心经验
J Neurol Surg B Skull Base. 2021 Feb 4;82(6):689-694. doi: 10.1055/s-0040-1715560. eCollection 2021 Dec.
8
High-Dose-Rate Brachytherapy for the Treatment of Basal and Squamous Cell Carcinomas on Sensitive Areas of the Face: A Report of Clinical Outcomes and Acute and Subacute Toxicities.高剂量率近距离放射治疗面部敏感区域基底细胞癌和鳞状细胞癌:临床结果及急慢性毒性报告
Adv Radiat Oncol. 2020 Dec 16;6(2):100616. doi: 10.1016/j.adro.2020.10.028. eCollection 2021 Mar-Apr.
9
Management of a complex scalp defect with cryopreserved placental membrane containing viable cells resulted in rapid wound closure.采用含有活细胞的冷冻保存胎盘膜治疗复杂头皮缺损,实现了伤口的快速闭合。
Clin Case Rep. 2020 Mar 6;8(4):757-760. doi: 10.1002/ccr3.2792. eCollection 2020 Apr.
10
Heterogeneous relationships of squamous and basal cell carcinomas of the skin with smoking: the UK Million Women Study and meta-analysis of prospective studies.皮肤鳞状细胞癌和基底细胞癌与吸烟的异质关系:英国百万妇女研究和前瞻性研究的荟萃分析。
Br J Cancer. 2018 Jul;119(1):114-120. doi: 10.1038/s41416-018-0105-y. Epub 2018 Jun 14.